BIO.News Newsletter

FDA Commissioner Dr. Robert M. Califf joined the final day of BIO International Convention—here’s what he said about Accelerated Approval, misinformation, and the things the agency does other than drugs. (776 words, 3 minutes, 52 seconds)

Day 3 of the BIO International Convention put a focus on Accelerated Approval—including its value and why it matters for patients. We also heard from patient advocates including the great Venus Williams about why patients’ stories are so important. (724 words, 3 minutes, 37 seconds)

We have new reports on VC funding for biotech and the value of federally funded research—plus, what happened during the Senate HELP Committee’s markup of FDA user fee legislation and more news from Day 2 of BIO International Convention. (842 words, 4 minutes, 12 seconds)

The theme of BIO Convention Day #1 was the importance of inclusion—from within companies, to the products we create, to ensuring access to clinical trials and innovation. Here’s what we learned—about how to measure and report DEI and ESG, why it’s a great time to invest in women’s health, plus more news from San Diego and inside the Beltway. (658 words, 3 minutes, 17 seconds)

The BIO International Convention is here—in person! We kick off with an exclusive preview of BIO’s diversity report, a forthcoming book on the orphan drug revolution, and how to follow our coverage—including our Good Day BIO LIVE! morning news show. All of that plus today’s news below. (928 words, 4 minutes, 38 seconds)

Before we head to the BIO International Convention, we have news on inflation and health care costs, the FTC’s plans to investigate pharmacy middlemen, and booming life sciences job growth. And be sure to check your inbox on Monday morning—we’ll be coming to you live from San Diego with something special! In the meantime, you can follow along on bio.news. (695 words, 3 minutes, 28 seconds)

The House passed FDA user fee reauthorization yesterday, which will help fund FDA research to bring more breakthroughs to patients. We have details and what’s next in the Senate. And with a soil shortage looming, a study finds regenerative farming can boost soil health and food nutrition. Plus, nominations are open for BIO’s George Washington Carver and Rosalind Franklin Awards – details below. (915 words, 4 minutes, 34 seconds)

Today, we have an exclusive look at how the industry is responding to monkeypox—thanks in large part to sustained investment in medical preparedness. Plus, an FDA advisory committee recommends emergency use authorization of the Novavax COVID-19 vaccine—so what’s next? (821 words, 4 minutes, 6 seconds)

A new study authored by a USDA researcher confirms what we already know: biotech improves farmers' ability to protect their crops against pests—and only pests. We have the details, plus why patient advocacy groups are calling on Congress to restore funding for COVID services for the uninsured. (587 words, 2 minutes, 56 seconds)

Back to work after recess and the new week begins with a remarkable cancer trial “first” on National Cancer Survivors Day, and how climate’s having an impact on farmers (and what biotech can do about it). (696 words, 3 minutes, 28 seconds)